nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0625	0.0625	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CGA—conduct disorder	0.0476	0.0476	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.035	0.035	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—HTR2A—conduct disorder	0.0345	0.0345	CbGpPWpGaD
Aprepitant—CYP1A2—Methylation—COMT—conduct disorder	0.0339	0.0339	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0318	0.0318	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0309	0.0309	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0305	0.0305	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CGA—conduct disorder	0.0269	0.0269	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—DRD4—conduct disorder	0.0267	0.0267	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CGA—conduct disorder	0.0244	0.0244	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0239	0.0239	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CGA—conduct disorder	0.0233	0.0233	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0229	0.0229	CbGpPWpGaD
Aprepitant—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0212	0.0212	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0195	0.0195	CbGpPWpGaD
Aprepitant—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—HTR2A—conduct disorder	0.0174	0.0174	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0171	0.0171	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—HTR2A—conduct disorder	0.0169	0.0169	CbGpPWpGaD
Aprepitant—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0163	0.0163	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—DRD4—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0149	0.0149	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CGA—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Aprepitant—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—DRD4—conduct disorder	0.0137	0.0137	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CGA—conduct disorder	0.0131	0.0131	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—DRD4—conduct disorder	0.013	0.013	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CGA—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—WASF1—conduct disorder	0.0116	0.0116	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0112	0.0112	CbGpPWpGaD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0108	0.0108	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—HTR2A—conduct disorder	0.00983	0.00983	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—HTR2A—conduct disorder	0.00893	0.00893	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—HTR2A—conduct disorder	0.0085	0.0085	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00835	0.00835	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—DRD4—conduct disorder	0.00809	0.00809	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00799	0.00799	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00793	0.00793	CbGpPWpGaD
Aprepitant—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00788	0.00788	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00761	0.00761	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—DRD4—conduct disorder	0.00736	0.00736	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CGA—conduct disorder	0.00705	0.00705	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—DRD4—conduct disorder	0.00668	0.00668	CbGpPWpGaD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0065	0.0065	CbGpPWpGaD
Aprepitant—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00595	0.00595	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00578	0.00578	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00574	0.00574	CbGpPWpGaD
Aprepitant—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—WASF1—conduct disorder	0.00565	0.00565	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HTR2A—conduct disorder	0.00528	0.00528	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00502	0.00502	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—HTR2A—conduct disorder	0.0048	0.0048	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00447	0.00447	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00443	0.00443	CbGpPWpGaD
Aprepitant—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.0044	0.0044	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HTR2A—conduct disorder	0.00436	0.00436	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00429	0.00429	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00429	0.00429	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00407	0.00407	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00404	0.00404	CbGpPWpGaD
Aprepitant—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00402	0.00402	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—DRD4—conduct disorder	0.00395	0.00395	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0038	0.0038	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00348	0.00348	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Aprepitant—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00343	0.00343	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CGA—conduct disorder	0.00303	0.00303	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—EP300—conduct disorder	0.00279	0.00279	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00269	0.00269	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00267	0.00267	CbGpPWpGaD
Aprepitant—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00265	0.00265	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HTR2A—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CGA—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CGA—conduct disorder	0.00169	0.00169	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CGA—conduct disorder	0.00154	0.00154	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—COMT—conduct disorder	0.00137	0.00137	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EP300—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MAOA—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CGA—conduct disorder	0.00132	0.00132	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CGA—conduct disorder	0.00102	0.00102	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—COMT—conduct disorder	0.000988	0.000988	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MAOA—conduct disorder	0.000981	0.000981	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—COMT—conduct disorder	0.000764	0.000764	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MAOA—conduct disorder	0.000758	0.000758	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000735	0.000735	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—COMT—conduct disorder	0.000696	0.000696	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MAOA—conduct disorder	0.000691	0.000691	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000671	0.000671	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—COMT—conduct disorder	0.000595	0.000595	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MAOA—conduct disorder	0.000591	0.000591	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—EP300—conduct disorder	0.000586	0.000586	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000573	0.000573	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—COMT—conduct disorder	0.000459	0.000459	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MAOA—conduct disorder	0.000456	0.000456	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—EP300—conduct disorder	0.000424	0.000424	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—EP300—conduct disorder	0.000328	0.000328	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—EP300—conduct disorder	0.000299	0.000299	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—EP300—conduct disorder	0.000255	0.000255	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—EP300—conduct disorder	0.000197	0.000197	CbGpPWpGaD
